The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended October 2025, The Cooper Companies (COO) reported revenue of $1.07 billion, up 4.6% over the same period last year. EPS came in at $1.15, compared to $1.04 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.06 billion, representing a surprise of +0.45%. The company delivered an EPS surprise of +3.6%, with the consensus EPS estimate being $1.11.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue by Geography- Americas: $285.1 million versus $291.49 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.4% change.Revenue by Geography- Asia Pacific: $147.4 million versus the two-analyst average estimate of $139.8 million. The reported number represents a year-over-year change of -1.3%.Revenue by Geography- EMEA: $277.1 million versus the two-analyst average estimate of $269.49 million. The reported number represents a year-over-year change of +8%.Revenue by Category- CVI: $709.6 million compared to the $707.83 million average estimate based on five analysts. The reported number represents a change of +4.9% year over year.Revenue by Category- CSI: $355 million versus $352.65 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.Revenue by Category- CSI- Office and surgical: $214.6 million versus $208.89 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.Revenue by Category- CSI- Fertility: $141 million compared to the $144.03 million average estimate based on four analysts. The reported number represents a change of +1.3% year over year.Revenue by Category- CVI- Sphere, other: $365 million compared to the $362.34 million average estimate based on four analysts. The reported number represents a change of +3.3% year over year.Revenue by Category- CVI- Toric and multifocal: $344.6 million versus $346.45 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.View all Key Company Metrics for The Cooper Companies here>>>Shares of The Cooper Companies have returned +10.3% over the past month versus the Zacks S&P 500 composite's +0.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Cooper Companies, Inc. (COO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks